Literature DB >> 12032546

p53 Stability and activity is regulated by Mdm2-mediated induction of alternative p53 translation products.

Yili Yin1, C W Stephen, M Gloria Luciani, Robin Fåhraeus.   

Abstract

Activation of the p53 tumour suppressor protein can lead to cell-cycle arrest or apoptosis. p53 function is controlled by the mdm2 oncogene product, which targets p53 for proteasomal degradation. In this report we demonstrate that Mdm2 induces translation of the p53 mRNA from two alternative initiation sites, giving full-length p53 and another protein with a relative molecular mass (M(r)) of approximately 47K; we designate this protein as p53/47. This translation induction requires Mdm2 to interact directly with the nascent p53 polypeptide. The alternatively translated p53/47 does not contain the Mdm2-binding site and it lacks the most amino-terminal transcriptional-activation domain of p53. Increased expression of p53/47 stabilizes p53 in the presence of Mdm2, and alters the expression levels of p53-induced gene products. These results show how the interaction of Mdm2 with p53 leads to a change in the ratio of full-length p53 to p53/47 by inducing translation of both p53 proteins and the subsequent selective degradation of full-length p53. Thus, Mdm2 controls the expression levels of p53 through a dual mechanism that involves induction of synthesis and targeting for degradation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032546     DOI: 10.1038/ncb801

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  109 in total

1.  Length and secondary structure of the 5' non-coding regions of mouse p53 mRNA transcripts - mouse as a model organism for p53 gene expression studies.

Authors:  Joanna Szpotkowska; Agata Swiatkowska; Jerzy Ciesiołka
Journal:  RNA Biol       Date:  2018-12-20       Impact factor: 4.652

2.  How many mutant p53 molecules are needed to inactivate a tetramer?

Authors:  Wan Mui Chan; Wai Yi Siu; Anita Lau; Randy Y C Poon
Journal:  Mol Cell Biol       Date:  2004-04       Impact factor: 4.272

3.  Modulation of mammalian life span by the short isoform of p53.

Authors:  Bernhard Maier; Wendy Gluba; Brian Bernier; Terry Turner; Khalid Mohammad; Theresa Guise; Ann Sutherland; Michael Thorner; Heidi Scrable
Journal:  Genes Dev       Date:  2004-02-01       Impact factor: 11.361

4.  p53 in stem cells.

Authors:  Valeriya Solozobova; Christine Blattner
Journal:  World J Biol Chem       Date:  2011-09-26

5.  Influence of parameter values on the oscillation sensitivities of two p53-Mdm2 models.

Authors:  Christian E Cuba; Alexander R Valle; Giancarlo Ayala-Charca; Elizabeth R Villota; Alberto M Coronado
Journal:  Syst Synth Biol       Date:  2015-06-05

6.  Reversible induction of translational isoforms of p53 in glucose deprivation.

Authors:  D Khan; A Katoch; A Das; A Sharathchandra; R Lal; P Roy; S Das; S Chattopadhyay; S Das
Journal:  Cell Death Differ       Date:  2015-02-27       Impact factor: 15.828

Review 7.  Dysfunction of the TP53 tumor suppressor gene in lymphoid malignancies.

Authors:  Zijun Y Xu-Monette; L Jeffrey Medeiros; Yong Li; Robert Z Orlowski; Michael Andreeff; Carlos E Bueso-Ramos; Timothy C Greiner; Timothy J McDonnell; Ken H Young
Journal:  Blood       Date:  2012-01-24       Impact factor: 22.113

8.  A bicistronic MAVS transcript highlights a class of truncated variants in antiviral immunity.

Authors:  Sky W Brubaker; Anna E Gauthier; Eric W Mills; Nicholas T Ingolia; Jonathan C Kagan
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

9.  miniMAVS, You Complete Me!

Authors:  Manira Rayamajhi; Edward A Miao; Nathaniel J Moorman
Journal:  Cell       Date:  2014-02-13       Impact factor: 41.582

Review 10.  p53--a Jack of all trades but master of none.

Authors:  Melissa R Junttila; Gerard I Evan
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.